Thorsten Simon
Hat mitgewirkt an:
-
Therapieergebnisse beim rezidivierten nodulär Lymphozyten-prädominanten Hodgkin Lymphom
-
Identification of CD133-positive cell populations within glioma cell lines
-
Long term outcome of high-risk neuroblastoma patients after immunotherapy with antibody ch14.18 or oral metronomic chemotherapy
-
Genetic alterations and resectability predict outcome in patients with neuroblastoma assigned to high-risk solely by MYCN amplification